PMS2 and cancer: Another finding was the ubiquitous loss of MLH1 protein in conjunction with PMS2 absence, implying dMMR and suggesting a potential use as surrogate biomarker for rhesus CRC diagnostics due to its clear-cut separation of cancer cell clusters and healthy tissue.